Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
Clinical trial NCT04508790 · RECRUITING
Trial details
- NCT number
- NCT04508790
- Sponsor
- City of Hope Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-24
- Primary completion
- 2027-02-14
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.